![DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update - Annals of Oncology DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0ae1ad2e-ac44-4935-9130-337df0ab12a8/gr1.jpg)
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update - Annals of Oncology
![PDF) Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas PDF) Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas](https://www.researchgate.net/publication/305323552/figure/fig1/AS:654744947281921@1533114768286/Mechanism-of-action-of-capecitabine-plus-gemcitabine-5-DFCR-5-deoxyfluorocytidine_Q320.jpg)
PDF) Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas
![Frontiers | Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment | Pharmacology Frontiers | Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment | Pharmacology](https://www.frontiersin.org/files/Articles/441613/fphar-10-00110-HTML-r1/image_m/fphar-10-00110-s002.jpg)